DOPTELET Trademark

Trademark Overview


On Thursday, June 22, 2017, a trademark application was filed for DOPTELET with the United States Patent and Trademark Office. The USPTO has given the DOPTELET trademark a serial number of 87501538. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, October 17, 2024. This trademark is owned by AkaRx, Inc.. The DOPTELET trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of thrombocytopenia disease
doptelet

General Information


Serial Number87501538
Word MarkDOPTELET
Filing DateThursday, June 22, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, October 17, 2024
Registration Number5551985
Registration DateTuesday, August 28, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 28, 2017

Trademark Statements


Description of MarkThe mark consists of the stylized wording "DOPTELET", with a pointed line curving upward starting above the "O", and with the line having a gradient darkening from left to right.
Goods and ServicesPharmaceutical preparations for the treatment of thrombocytopenia disease
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 29, 2017
Primary Code005
First Use Anywhere DateThursday, June 14, 2018
First Use In Commerce DateThursday, June 14, 2018

Trademark Owner History


Party NameAkaRx, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMorrisville, NC 27560

Party NameAkaRx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCharlottesville, VA 22902

Party NameAkaRx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCharlottesville, VA 22902

Trademark Events


Event DateEvent Description
Thursday, September 21, 2017EXAMINER'S AMENDMENT ENTERED
Monday, June 26, 2017NEW APPLICATION ENTERED
Thursday, June 29, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 30, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, September 20, 2017ASSIGNED TO EXAMINER
Thursday, September 21, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, September 21, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 21, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, July 19, 2018STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 4, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 20, 2017ASSIGNED TO LIE
Wednesday, November 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 28, 2017PUBLISHED FOR OPPOSITION
Tuesday, November 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 23, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 26, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, June 26, 2018USE AMENDMENT FILED
Thursday, July 19, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 23, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 24, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 28, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, November 1, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 1, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 28, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 19, 2024TEAS SECTION 8 & 15 RECEIVED
Thursday, October 17, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, October 17, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, October 17, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED